| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.866 | 17.499 | 17.866 | 21.651 | 25.309 | 36.885 | 27.792 | 26.862 | 38.071 | 47.555 |
| Total Income - EUR | 13.928 | 17.777 | 17.974 | 21.691 | 25.393 | 37.045 | 28.488 | 26.878 | 39.800 | 47.563 |
| Total Expenses - EUR | 9.032 | 10.206 | 14.276 | 13.528 | 8.310 | 10.146 | 22.361 | 23.293 | 14.877 | 15.572 |
| Gross Profit/Loss - EUR | 4.896 | 7.571 | 3.698 | 8.163 | 17.083 | 26.899 | 6.127 | 3.585 | 24.923 | 31.991 |
| Net Profit/Loss - EUR | 4.476 | 7.040 | 3.150 | 7.659 | 16.449 | 26.073 | 5.513 | 3.118 | 24.545 | 31.587 |
| Employees | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioabc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.963 | 3.378 | 2.270 | 1.198 | 163 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 13.877 | 6.320 | 21.898 | 25.949 | 39.541 | 56.172 | 59.883 | 57.797 | 74.863 | 97.774 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.472 | 4.813 | 17.469 | 16.411 | 17.555 | 17.586 | 16.129 | 26.020 | 58.662 | 78.479 |
| Cash | 10.405 | 1.506 | 4.429 | 9.538 | 21.986 | 38.585 | 43.754 | 31.777 | 16.200 | 19.296 |
| Shareholders Funds | 13.379 | 7.970 | 10.985 | 18.442 | 34.534 | 54.811 | 59.108 | 56.288 | 73.510 | 96.164 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.461 | 1.728 | 13.184 | 8.704 | 5.171 | 1.361 | 775 | 1.510 | 1.353 | 1.610 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Bioabc S.r.l.